214 related articles for article (PubMed ID: 9330173)
1. Glutaraldehyde detoxification of aortic wall tissue: a promising perspective for emerging bioprosthetic valve concepts.
Zilla P; Fullard L; Trescony P; Meinhart J; Bezuidenhout D; Gorlitzer M; Human P; von Oppell U
J Heart Valve Dis; 1997 Sep; 6(5):510-20. PubMed ID: 9330173
[TBL] [Abstract][Full Text] [Related]
2. Diamine-extended glutaraldehyde- and carbodiimide crosslinks act synergistically in mitigating bioprosthetic aortic wall calcification.
Zilla P; Bezuidenhout D; Torrianni M; Hendriks M; Human P
J Heart Valve Dis; 2005 Jul; 14(4):538-45. PubMed ID: 16116882
[TBL] [Abstract][Full Text] [Related]
3. Glutaraldehyde detoxification in addition to enhanced amine cross-linking dramatically reduces bioprosthetic tissue calcification in the rat model.
Weissenstein C; Human P; Bezuidenhout D; Zilla P
J Heart Valve Dis; 2000 Mar; 9(2):230-40. PubMed ID: 10772041
[TBL] [Abstract][Full Text] [Related]
4. Preseeding with autologous fibroblasts improves endothelialization of glutaraldehyde-fixed porcine aortic valves.
Gulbins H; Goldemund A; Anderson I; Haas U; Uhlig A; Meiser B; Reichart B
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):592-601. PubMed ID: 12658201
[TBL] [Abstract][Full Text] [Related]
5. Detoxification on top of enhanced, diamine-extended glutaraldehyde fixation significantly reduces bioprosthetic root calcification in the sheep model.
Trantina-Yates AE; Human P; Zilla P
J Heart Valve Dis; 2003 Jan; 12(1):93-100; discussion 100-1. PubMed ID: 12578343
[TBL] [Abstract][Full Text] [Related]
6. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study.
Simionescu DT; Lovekamp JJ; Vyavahare NR
J Heart Valve Dis; 2003 Mar; 12(2):226-34. PubMed ID: 12701796
[TBL] [Abstract][Full Text] [Related]
7. High glutaraldehyde concentrations reduce rather than increase the calcification of aortic wall tissue.
Zilla P; Weissenstein C; Bracher M; Zhang Y; Koen W; Human P; von Oppell U
J Heart Valve Dis; 1997 Sep; 6(5):502-9. PubMed ID: 9330172
[TBL] [Abstract][Full Text] [Related]
8. Fixation-related autolysis and bioprosthetic aortic wall calcification.
Human P; Weissenstein C; Trantina A; Zilla P
J Heart Valve Dis; 2001 Sep; 10(5):656-65. PubMed ID: 11603606
[TBL] [Abstract][Full Text] [Related]
9. Diamine extension of glutaraldehyde crosslinks mitigates bioprosthetic aortic wall calcification in the sheep model.
Zilla P; Bezuidenhout D; Weissenstein C; van der Walt A; Human P
J Biomed Mater Res; 2001 Jul; 56(1):56-64. PubMed ID: 11309791
[TBL] [Abstract][Full Text] [Related]
10. Improved ultrastructural preservation of bioprosthetic tissue.
Zilla P; Zhang Y; Human P; Koen W; von Oppell U
J Heart Valve Dis; 1997 Sep; 6(5):492-501. PubMed ID: 9330171
[TBL] [Abstract][Full Text] [Related]
11. ADAPT-treated porcine valve tissue (cusp and wall) versus Medtronic Freestyle and Prima Plus: crosslink stability and calcification behavior in the subcutaneous rat model.
Neethling WM; Glancy R; Hodge AJ
J Heart Valve Dis; 2004 Jul; 13(4):689-96; discussion 696. PubMed ID: 15311879
[TBL] [Abstract][Full Text] [Related]
12. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration.
Simionescu DT; Lovekamp JJ; Vyavahare NR
J Heart Valve Dis; 2003 Mar; 12(2):217-25. PubMed ID: 12701795
[TBL] [Abstract][Full Text] [Related]
13. Viscoelasticity of dynamically fixed bioprosthetic valves. II. Effect of glutaraldehyde concentration.
Duncan AC; Boughner D; Vesely I
J Thorac Cardiovasc Surg; 1997 Feb; 113(2):302-10. PubMed ID: 9040624
[TBL] [Abstract][Full Text] [Related]
14. The anticalcific effect of glutaraldehyde detoxification on bioprosthetic aortic wall tissue in the sheep model.
Zilla P; Weissenstein C; Bracher M; Human P
J Card Surg; 2001; 16(6):467-72. PubMed ID: 11925027
[TBL] [Abstract][Full Text] [Related]
15. Mitigation of bioprosthetic heart valve degeneration through biocompatibility: in vitro versus spontaneous endothelialization.
Trantina-Yates AE; Human P; Bracher M; Zilla P
Biomaterials; 2001 Jul; 22(13):1837-46. PubMed ID: 11396888
[TBL] [Abstract][Full Text] [Related]
16. Optimization of diamine bridges in glutaraldehyde treated bioprosthetic aortic wall tissue.
Huma P; Bezuidenhout D; Torrianni M; Hendriks M; Zilla P
Biomaterials; 2002 May; 23(10):2099-103. PubMed ID: 11962649
[TBL] [Abstract][Full Text] [Related]
17. Carbodiimide treatment dramatically potentiates the anticalcific effect of alpha-amino oleic acid on glutaraldehyde-fixed aortic wall tissue.
Zilla P; Bezuidenhout D; Human P
Ann Thorac Surg; 2005 Mar; 79(3):905-10. PubMed ID: 15734403
[TBL] [Abstract][Full Text] [Related]
18. Ethanol inhibition of porcine bioprosthetic heart valve cusp calcification is enhanced by reduction with sodium borohydride.
Connolly JM; Alferiev I; Kronsteiner A; Lu Z; Levy RJ
J Heart Valve Dis; 2004 May; 13(3):487-93. PubMed ID: 15222297
[TBL] [Abstract][Full Text] [Related]
19. Effect of 2-amino oleic acid exposure conditions on the inhibition of calcification of glutaraldehyde cross-linked porcine aortic valves.
Chen W; Kim JD; Schoen FJ; Levy RJ
J Biomed Mater Res; 1994 Dec; 28(12):1485-95. PubMed ID: 7876288
[TBL] [Abstract][Full Text] [Related]
20. Porcine stentless bioprostheses: prevention of aortic wall calcification by dye-mediated photo-oxidation.
Meuris B; Phillips R; Moore MA; Flameng W
Artif Organs; 2003 Jun; 27(6):537-43. PubMed ID: 12780508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
